Dr. Ati recently onboarded a new patient in our trial app.
Mrs. Maryam A., a 70-year-old female with a history of Osteoporosis and Hyperlipidemia, is on Atorvastatin and Bisphosphonate. Despite consulting her GP in London multiple times over a year of palpitations, she wasn't diagnosed with any heart disease. She was, however, referred for Holter monitoring due to irregularities noted on her ECG.

In July 2022, she went to Italy with her husband and contracted COVID-19 during the first week. She experienced light headaches, general fatigue, and a slight cough.
Without knowledge of her medical history, Italian doctors advised only Paracetamol and rest. Ten days later, her Covid PCR test was negative, but two weeks after that, she faced severe headaches, vertigo, palpitations, and dyspnea, collapsing with weakness in her left arm and leg. She was admitted to the hospital, where her brain CT scan and ECG revealed a CVA (due to a large clot) and Atrial Fibrillation. Fortunately, the antiplatelet drug was administered in time, leading to her near-complete recovery.

What was the problem with her diagnosis?
There was no Artificial Intelligence (AI) algorithm that associated heart irregularities (e.g., AF) with a higher risk of COVID-19-induced clots.
COVID-19 and Blood Clots | Harvard Medical School
Coronavirus and Blood Clots: Risks, Complications, Prevention | Healthline

With the MarvsAI Healthscanner web app, it was possible to notify the medical team about a patient’s past medical history. In this case, MarvsAI could have alerted them about her ECG irregularities, which would have been useful during her COVID-19 care. Mrs. Maryam A. is now participating in the MarvsAI App trial.